American International Group, Inc. Aclaris Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.92 - $1.44 $270 - $423	-294 Reduced 0.85%	34,229 $42,000
Q4 2023 Feb 13, 2024	SELL	$0.64 - $6.49 $88 - $895	-138 Reduced 0.4%	34,523 $36,000
Q3 2023 Nov 13, 2023	BUY	$6.56 - $10.95 $8,081 - $13,490	1,232 Added 3.69%	34,661 $237,000
Q2 2023 Aug 04, 2023	BUY	$7.89 - $10.64 $17,744 - $23,929	2,249 Added 7.21%	33,429 $346,000
Q1 2023 May 12, 2023	BUY	$7.07 - $17.95 $4,383 - $11,129	620 Added 2.03%	31,180 $252,000
Q4 2022 Feb 10, 2023	SELL	$14.33 - $18.37 $1,576 - $2,020	-110 Reduced 0.36%	30,560 $481,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $34,883 - $48,629	2,669 Added 9.53%	30,670 $483,000
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $27,208 - $45,740	2,678 Added 10.58%	28,001 $391,000
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $17,366 - $31,951	-1,783 Reduced 6.58%	25,323 $437,000
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $9,950 - $14,995	-811 Reduced 2.91%	27,106 $394,000
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $48,020 - $67,473	3,589 Added 14.75%	27,917 $503,000
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $415,522 - $720,108	24,328 New	24,328 $427,000
Q2 2020 Aug 12, 2020	SELL	$1.04 - $1.73 $18,970 - $31,556	-18,241 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$0.75 - $2.18 $789 - $2,295	-1,053 Reduced 5.46%	18,241 $19,000
Q4 2019 Feb 05, 2020	SELL	$1.02 - $1.97 $166 - $321	-163 Reduced 0.84%	19,294 $36,000
Q3 2019 Nov 08, 2019	SELL	$0.79 - $2.47 $106 - $333	-135 Reduced 0.69%	19,457 $21,000
Q2 2019 Aug 13, 2019	SELL	$2.13 - $7.06 $6,355 - $21,067	-2,984 Reduced 13.22%	19,592 $43,000
Q1 2019 May 06, 2019	SELL	$5.63 - $7.84 $4,115 - $5,731	-731 Reduced 3.14%	22,576 $135,000
Q4 2018 Feb 13, 2019	BUY	$6.3 - $15.4 $35,122 - $85,855	5,575 Added 31.44%	23,307 $172,000
Q3 2018 Nov 09, 2018	BUY	$14.38 - $20.89 $4,572 - $6,643	318 Added 1.83%	17,732 $257,000
Q2 2018 Aug 08, 2018	BUY	$16.46 - $20.33 $42,038 - $51,922	2,554 Added 17.19%	17,414 $348,000
Q1 2018 May 07, 2018	SELL	$17.08 - $25.64 $13,646 - $20,486	-799 Reduced 5.1%	14,860 $260,000
Q4 2017 Feb 09, 2018	BUY	$21.47 - $27.8 $46,096 - $59,686	2,147 Added 15.89%	15,659 $386,000
Q3 2017 Nov 09, 2017	BUY	$23.02 - $28.8 $311,046 - $389,145	13,512	13,512 $349,000

Others Institutions Holding ACRS

# of Institutions

100

Shares Held

52.2M

Call Options Held

32.4K

Put Options Held

3.3K

Bml Capital Management, LLC Zionsville, IN

13M
Shares

$15.2 Million
10.2% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$5.48 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.34M
Shares

$3.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.32M
Shares

$3.88 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$3.22 Million
0.09% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $78M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account